Publications en collaboration avec des chercheurs de University of Birmingham (21)

2025

  1. A network approach exploring the effects of cognitive remediation on cognition, symptoms, and functioning in early psychosis

    Psychological Medicine, Vol. 55

  2. Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program

    Schizophrenia Bulletin Open, Vol. 6, Núm. 1

  3. Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program

    Schizophrenia, Vol. 11, Núm. 1

  4. Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program

    Schizophrenia Bulletin Open, Vol. 6, Núm. 1

  5. Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program

    Schizophrenia, Vol. 11, Núm. 1

  6. The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program

    Schizophrenia, Vol. 11, Núm. 1

  7. The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures

    Schizophrenia, Vol. 11, Núm. 1

2024

  1. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

    Schizophrenia bulletin, Vol. 50, Núm. 3, pp. 496-512

  2. Cognitive remediation therapy to enhance cognition and improve recovery in early psychosis: the ECLIPSE research programme including an RCT

    Programme Grants for Applied Research, Vol. 12, Núm. 4

  3. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

    Early Intervention in Psychiatry, Vol. 18, Núm. 4, pp. 255-272

  4. Understanding the Mechanisms of Cognitive Remediation on Recovery in People With Early Psychosis: A Mediation and Moderation Analysis

    Schizophrenia bulletin, Vol. 50, Núm. 6, pp. 1371-1381

2023

  1. Cognitive Remediation Works But How Should We Provide It? An Adaptive Randomized Controlled Trial of Delivery Methods Using a Patient Nominated Recovery Outcome in First-Episode Participants

    Schizophrenia bulletin, Vol. 49, Núm. 3, pp. 614-625

  2. Predicting treatment resistance from first-episode psychosis using routinely collected clinical information

    Nature Mental Health, Vol. 1, Núm. 1, pp. 25-35

  3. Satisfaction with cognitive remediation therapy: its effects on implementation and outcomes using the cognitive remediation satisfaction scale

    Schizophrenia, Vol. 9, Núm. 1

2021

  1. Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function

    Translational Psychiatry, Vol. 11, Núm. 1

  2. Correction: Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function (Translational Psychiatry, (2021), 11, 1, (579), 10.1038/s41398-021-01705-z)

    Translational Psychiatry

  3. Development and external validation of the Psychosis Metabolic Risk Calculator (PsyMetRiC): a cardiometabolic risk prediction algorithm for young people with psychosis

    The Lancet Psychiatry, Vol. 8, Núm. 7, pp. 589-598

  4. Integrated metastate functional connectivity networks predict change in symptom severity in clinical high risk for psychosis

    Human Brain Mapping, Vol. 42, Núm. 2, pp. 439-451

2020

  1. Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association with Clinical Outcome

    Schizophrenia Bulletin, Vol. 46, Núm. 3, pp. 670-679

2018

  1. The CIRCuiTS study (Implementation of cognitive remediation in early intervention services): Protocol for a randomised controlled trial

    Trials, Vol. 19, Núm. 1